Honours pharma companies with Outstanding Export Performance Award
Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently organised the 9th Edition of Outstanding Export Performance Award in Hyderabad.
HighTide Therapeutics announced that it will present at the EASL Congress 2025. The presentations include New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010).